1.  17
    Device representatives in hospitals: are commercial imperatives driving clinical decision-making?Quinn Grundy, Katrina Hutchison, Jane Johnson, Brette Blakely, Robyn Clay-Wlliams, Bernadette Richards & Wendy A. Rogers - 2018 - Journal of Medical Ethics 44 (9):589-592.
    Despite concerns about the relationships between health professionals and the medical device industry, the issue has received relatively little attention. Prevalence data are lacking; however, qualitative and survey research suggest device industry representatives, who are commonly present in clinical settings, play a key role in these relationships. Representatives, who are technical product specialists and not necessarily medically trained, may attend surgeries on a daily basis and be available to health professionals 24 hours a day, 7 days a week, to provide (...)
    Direct download (5 more)  
    Export citation  
    Bookmark   3 citations  
  2.  40
    On the fragility of medical virtue in a neoliberal context: the case of commercial conflicts of interest in reproductive medicine.Christopher Mayes, Brette Blakely, Ian Kerridge, Paul Komesaroff, Ian Olver & Wendy Lipworth - 2016 - Theoretical Medicine and Bioethics 37 (1):97-111.
    Social, political, and economic environments play an active role in nurturing professional virtue. Yet, these environments can also lead to the erosion of virtue. As such, professional virtue is fragile and vulnerable to environmental shifts. While physicians are often considered to be among the most virtuous of professional groups, concern has also always existed about the impact of commercial arrangements on physicians’ willingness and capacity to enact their professional virtues. This article examines the ways in which commercial arrangements have been (...)
    Direct download (3 more)  
    Export citation  
    Bookmark   2 citations  
  3.  2
    Ethical and regulatory implications of the COVID-19 pandemic for the medical devices industry and its representatives.Guy Maddern, Bernadette Richards, Robyn Clay-Williams, Katrina Hutchison, Quinn Grundy, Jane Johnson, Wendy Rogers & Brette Blakely - 2022 - BMC Medical Ethics 23 (1):1-7.
    The development and deployment of medical devices, along with most areas of healthcare, has been significantly impacted by the COVID-19 pandemic. This has had variable ethical implications, two of which we will focus on here. First, medical device regulations have been rapidly amended to expedite approvals of devices ranging from face masks to ventilators. Although some regulators have issued cessation dates, there is inadequate discussion of triggers for exiting these crisis standards, and evidence that this may not be feasible. Given (...)
    No categories
    Direct download (3 more)  
    Export citation